Recipharm site in France approved for supply of product to Japan
Recipharm’s solid dose facility located in Fontaine, France, has been approved for supply to the Japanese market following a recent inspection by the Japanese drug agency called PMDA.
The dossier was presented by one of the existing customers and was also approved. Stéphane Guisado, Recipharm Fontaine´s General Manager, comments “We are very pleased to have secured this approval. Supplying products to Japan involves a lot of additional activities and challenges such as required enhanced quality control which we have had to overcome. We were also able to draw upon experience from other Recipharm sites which are already supplying this key market. As a result of this approval we are now in a good position to further support other customers with their growth plans in this important market.”